Nath Bio-Genes (India) Limited
NSE: NATHBIOGEN BSE: NATHBIOGEN
Prev Close
164.91
Open Price
164.91
Volume
62,052
Today Low / High
163.25 / 167.59
52 WK Low / High
137.55 / 238.69
Range
156 - 172
Prev Close
164.6
Open Price
164.6
Volume
5,403
Today Low / High
164.1 / 169.75
52 WK Low / High
141.1 / 238
Range
159 - 176
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 164.1 (target range: 156 - 172), reflecting a change of -0.81 (-0.49118%). On the BSE, it is listed at 167.4 (target range: 159 - 176), showing a change of 2.8 (1.70109%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Nath Bio-Genes (India) Limited Graph
Nath Bio-Genes (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Nath Bio-Genes (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 164.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 167.40 | 169.07 | 152.17 - 185.98 |
170.75 | 136.60 - 204.90 | ||
172.42 | 120.70 - 224.15 | ||
Bearish Scenario | 167.40 | 165.73 | 149.15 - 182.30 |
164.05 | 131.24 - 196.86 | ||
162.38 | 113.66 - 211.09 |
Overview of Nath Bio-Genes (India) Limited
ISIN
INE448G01010
Industry
Agricultural Inputs
Vol.Avg
34,680
Market Cap
3,118,556,400
Last Dividend
2
Official Website
IPO Date
2014-01-28
DCF Diff
-199.96
DCF
364
Financial Ratios Every Investor Needs
Stock Dividend of NATHBIOGEN
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-08-14 | August 14, 25 | 2 | 2 | 2025-08-14 | 2025-09-21 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 364.91 Cr | 135.55 Cr | 229.36 Cr | 0.6285 | 0.00 Cr | 32.50 Cr | 45.98 Cr | 38.60 Cr | 20.31 | 49.80 Cr | 0.1058 |
2024-03-31 | 247.53 Cr | 144.41 Cr | 103.11 Cr | 0.4166 | 11.28 Cr | 7.29 Cr | 47.70 Cr | 39.62 Cr | 20.85 | 53.64 Cr | 0.1601 |
2023-03-31 | 301.29 Cr | 134.59 Cr | 166.70 Cr | 0.5533 | 9.37 Cr | 5.68 Cr | 173.31 Cr | 35.01 Cr | 18.42 | 48.89 Cr | 0.1162 |
2022-03-31 | 278.36 Cr | 123.97 Cr | 154.39 Cr | 0.5546 | 8.89 Cr | 6.60 Cr | 137.60 Cr | -67.34 Cr | -35.43 | -49.71 Cr | -0.2419 |
2021-03-31 | 307.34 Cr | 136.09 Cr | 171.25 Cr | 0.5572 | 9.15 Cr | 5.09 Cr | 65.23 Cr | 55.66 Cr | 29.29 | 68.43 Cr | 0.1811 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 88.90 Cr | 1,026.21 Cr | 381.82 Cr | 644.3871 Cr | 122.50 Cr | 33.60 Cr | 338.02 Cr | 243.19 Cr | 0.00 Cr | 0.00 Cr | 5.78 Cr | 365.3008 Cr |
2024-03-31 | 77.40 Cr | 880.23 Cr | 270.31 Cr | 609.9187 Cr | 110.35 Cr | 32.94 Cr | 230.31 Cr | 281.52 Cr | 64.60 Cr | 0.00 Cr | 16.95 Cr | 262.4470 Cr |
2023-03-31 | 38.00 Cr | 792.80 Cr | 219.62 Cr | 573.1733 Cr | 105.21 Cr | 67.22 Cr | 207.85 Cr | 233.96 Cr | 0.87 Cr | 0.00 Cr | 5.05 Cr | 216.4534 Cr |
2022-03-31 | 4.17 Cr | 741.91 Cr | 199.94 Cr | 541.9695 Cr | 92.96 Cr | 88.79 Cr | 220.34 Cr | 232.85 Cr | 23.84 Cr | 0.00 Cr | 5.05 Cr | 194.2909 Cr |
2021-03-31 | 29.21 Cr | 789.51 Cr | 176.23 Cr | 613.2788 Cr | 96.57 Cr | 67.36 Cr | 226.30 Cr | 233.30 Cr | 2.53 Cr | 0.00 Cr | 5.05 Cr | 173.0038 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 17.5814 Cr | -3.9620 Cr | -2.1301 Cr | 9.6610 Cr | 11.4893 Cr | 88.8992 Cr | -7.9204 Cr | 38.5998 Cr | 12.1545 Cr | -3.8008 Cr | -107.7068 Cr |
2024-03-31 | 74.5937 Cr | -27.4011 Cr | -7.7780 Cr | 47.8181 Cr | 39.4147 Cr | 77.4099 Cr | -26.7756 Cr | 41.5647 Cr | 5.1341 Cr | -3.8008 Cr | -22.4625 Cr |
2023-03-31 | 38.3668 Cr | -2.8840 Cr | -1.6682 Cr | 35.8180 Cr | 33.8146 Cr | 37.9952 Cr | -2.5488 Cr | 36.1643 Cr | 12.2537 Cr | -3.8008 Cr | 12.4962 Cr |
2022-03-31 | 17.0463 Cr | -19.8664 Cr | -22.2266 Cr | -3.9703 Cr | -25.0481 Cr | 4.1680 Cr | -21.0166 Cr | -63.3865 Cr | -7.8202 Cr | -3.8008 Cr | 5.9571 Cr |
2021-03-31 | 1.1129 Cr | -10.2822 Cr | 16.4007 Cr | -10.4856 Cr | 7.2313 Cr | 29.2161 Cr | -11.5984 Cr | 56.7511 Cr | 25.2201 Cr | 0.0000 Cr | -21.9918 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 283.70 Cr | 139.82 Cr | 143.88 Cr | 0.5071 | 37.31 Cr | 37.28 Cr | 18.50 | 40.05 Cr | 0.1314 |
2025-03-31 | 51.97 Cr | 17.68 Cr | 34.29 Cr | 0.6598 | -0.93 Cr | 1.48 Cr | 0.45 | 4.28 Cr | 0.0285 |
2024-12-31 | 36.87 Cr | 12.49 Cr | 24.39 Cr | 0.6613 | 7.21 Cr | 2.65 Cr | 1.33 | 8.51 Cr | 0.0719 |
2024-09-30 | 32.19 Cr | 22.23 Cr | 9.97 Cr | 0.3096 | 3.99 Cr | 1.11 Cr | 0.53 | 4.89 Cr | 0.0346 |
2024-06-30 | 243.88 Cr | 130.48 Cr | 113.40 Cr | 0.4650 | 35.71 Cr | 33.35 Cr | 17.55 | 36.67 Cr | 0.1368 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 0.00 Cr | 0.00 Cr | 88.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -644.39 Cr |
2025-03-31 | 88.90 Cr | 0.00 Cr | 88.90 Cr | 88.90 Cr | 338.02 Cr | 690.01 Cr | 243.19 Cr | 1,026.21 Cr | 381.82 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 2.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -640.27 Cr |
2024-09-30 | 2.08 Cr | 0.00 Cr | 2.08 Cr | 147.71 Cr | 167.14 Cr | 515.62 Cr | 243.04 Cr | 828.48 Cr | 188.21 Cr |
2024-06-30 | 0.00 Cr | 0.00 Cr | 77.41 Cr | 0.00 Cr | 0.00 Cr | 77.41 Cr | 0.00 Cr | 0.00 Cr | -609.92 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 37.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2025-03-31 | 1.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-12-31 | 2.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 1.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | 33.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
No split history data available. |
Similar Stocks: Agricultural Inputs
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Coromandel International Limited | COROMANDEL | ₹2,250.00 | ₹662,905,820,250.00 | ₹320,478.00 |
The Fertilisers And Chemicals Travancore Limited | FACT | ₹887.05 | ₹573,985,194,537.00 | ₹184,234.00 |
UPL Limited | UPL | ₹661.00 | ₹558,170,466,163.00 | ₹1,196,758.00 |
PI Industries Limited | PIIND | ₹3,562.20 | ₹540,410,255,060.00 | ₹91,416.00 |
Sumitomo Chemical India Limited | SUMICHEM | ₹544.00 | ₹271,535,280,384.00 | ₹193,959.00 |
Bayer CropScience Limited | BAYERCROP | ₹4,922.00 | ₹221,204,976,824.00 | ₹21,717.00 |
Chambal Fertilisers and Chemicals Limited | CHAMBLFERT | ₹511.50 | ₹204,933,649,916.00 | ₹605,448.00 |
Paradeep Phosphates Limited | PARADEEP | ₹195.70 | ₹159,455,740,610.00 | ₹10,478,358.00 |
Rashtriya Chemicals and Fertilizers Limited | RCF | ₹146.85 | ₹81,015,397,485.00 | ₹900,073.00 |
Gujarat State Fertilizers & Chemicals Limited | GSFC | ₹197.00 | ₹78,500,073,410.00 | ₹962,645.00 |
Sharda Cropchem Limited | SHARDACROP | ₹816.45 | ₹73,660,523,143.00 | ₹151,919.00 |
Dhanuka Agritech Limited | DHANUKA | ₹1,533.70 | ₹69,294,794,466.00 | ₹25,551.00 |
Rallis India Limited | RALLIS | ₹307.90 | ₹59,876,971,231.00 | ₹381,988.00 |
National Fertilizers Limited | NFL | ₹93.42 | ₹45,829,834,128.00 | ₹582,095.00 |
Bharat Rasayan Limited | BHARATRAS | ₹10,011.00 | ₹41,598,387,948.00 | ₹960.00 |
NACL Industries Limited | NACLIND | ₹203.49 | ₹40,987,934,994.00 | ₹412,414.00 |
Mangalore Chemicals & Fertilizers Limited | MANGCHEFER | ₹328.95 | ₹38,985,558,593.00 | ₹647,853.00 |
Madhya Bharat Agro Products Limited | MBAPL | ₹386.65 | ₹33,880,956,351.00 | ₹200,214.00 |
Bhagiradha Chemicals & Industries Limited | BHAGCHEM | ₹259.05 | ₹33,590,775,174.00 | ₹107,948.00 |
Krishana Phoschem Limited | KRISHANA | ₹444.00 | ₹27,428,854,800.00 | ₹425,097.00 |
Key Executives
Gender: female
Year Born: 1948
Gender: Not Specified
Year Born: 1972
Gender: male
Year Born:
Gender: male
Year Born: 1957
Gender: male
Year Born:
Gender: male
Year Born: 1995
Gender: male
Year Born: 1966
FAQs about Nath Bio-Genes (India) Limited
The CEO is Satish Kagliwal.
The current price is ₹164.10.
The range is ₹137.55-238.69.
The market capitalization is ₹311.86 crores.
The dividend yield is 1.22%.
The P/E ratio is 7.35.
The company operates in the Basic Materials sector.
Overview of Nath Bio-Genes (India) Limited (ISIN: INE448G01010) is a leading Agricultural Inputs in India. With a market capitalization of ₹311.86 crores and an average daily volume of 34,680 shares, it operates in the Agricultural Inputs. The company last declared a dividend of ₹2.